If you have been diagnosed with acromegaly, you may be interested in participating in a new clinical study evaluating the safety and effectiveness of an investigational oral study drug for acromegaly.
Qualified candidates will:
• be men or women 18 years of age or older
• have a confirmed diagnosis of acromegaly
• have been treated with long-acting octreotide or lanreotide for at least 12 weeks
Additional eligibility criteria also apply.
Study participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/acromegaly/